If you live in the U.S., you’re probably starting to feel the effects of ragweed pollen. Ragweed pollen allergy is one of the most common weed allergies. Its light pollen easily spreads far and wide, causing people with nasal and allergic asthma symptoms to feel miserable each fall.
AAFA has joined with four other nonprofit organizations that serve people with eczema to launch “More Than Skin Deep.” This project will inform and shape the development of treatments for eczema. A main part the project is a patient-focused drug development (PFDD) meeting on Sept. 23, 2019, in Washington, D.C.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat severe atopic dermatitis in children aged 6 to 11 years met its primary and secondary endpoints. Dupixent is the first and only biologic to show positive results in this pediatric atopic dermatitis population.
The Internal Revenue Service (IRS) recently made a change that could affect preventive asthma care. This change means some of your asthma medicines may become more affordable if you have a high deductible health plan (HDHP).
Growing up, Jerica Gordon’s sister had asthma, but she does not remember her having any asthma attacks. “So when my son was having trouble breathing, I thought it was just congestion or something. There was no wheezing that I remember hearing,” she shared. In November 2016, Jerica took her son Jonathan Robinson, Jr., then age 5, to the emergency room.
When you lay your head on your pillow at night, all you want to think about is comfort – not millions of dust mites. And if you have a dust mite allergy, having all those microscopic insects near your head can make you uncomfortable by triggering allergy and asthma symptoms. You can create a healthier sleeping environment by using pillows that are CERTIFIED asthma & allergy friendly®. Or you can cover your existing pillow in a CERTIFIED pillow cover.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application to provide information on inhaler use to people with asthma.
The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity). This is the first treatment approved for inadequately controlled chronic rhinosinusis with nasal polyps.
Did you know you may be able to tell when an asthma episode or attack is about to start before you have trouble breathing? Knowing your early warning signs (or mild symptoms) can be helpful so you can begin asthma treatment as soon as possible.
Did you know pollen might be responsible for your food allergy? If your mouth or throat itch when you eat certain fruit or vegetables, you could have oral allergy syndrome (OAS). And you would have a pollen allergy to thank for that.
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Out of the 25 million people who have asthma, about 60% of them have allergic asthma. If you have allergic asthma, this means allergens trigger asthma symptoms. Immunotherapy may help allergic asthma symptoms.
AAFA applauds the warning the U.S. Department of Transportation (USDOT) issued to American Airlines in response to American Airline’s denial of the right to pre-board a family of a child with food allergies. However, AAFA calls on the USDOT and Congress to take even stronger actions to protect the rights of airline passengers with allergies and all disabilities.
Four years ago, Deborah Bartlett of New Haven, Connecticut (overall #11 on Asthma Capitals), was diagnosed with severe persistent asthma. Combined with her pollen and mold allergies, as well as COPD, breathing can be a real challenge.